End Cash: The amount of cash held by the company for the given period.
Annovis Bio, Inc. (ANVS) had End Cash of $10.55M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.59M |
|
-- |
|
-- |
|
$26.69M |
|
$-26.69M |
|
$2.10M |
|
$-24.59M |
|
$-24.59M |
|
$-24.59M |
|
$-24.59M |
|
$-24.59M |
|
$-24.59M |
|
$-26.69M |
|
$-26.69M |
|
12.18M |
|
12.24M |
|
$-2.02 |
|
$-2.31 |
|
| Balance Sheet Financials | |
$13.93M |
|
-- |
|
-- |
|
$13.93M |
|
$3.88M |
|
-- |
|
$0.74M |
|
$4.62M |
|
$9.31M |
|
$9.31M |
|
$9.31M |
|
14.14M |
|
| Cash Flow Statement Financials | |
$-21.89M |
|
-- |
|
$26.69M |
|
$5.75M |
|
|
End Cash |
$10.55M |
$4.80M |
|
$3.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-264.19% |
|
-264.20% |
|
-176.58% |
|
-264.20% |
|
$0.66 |
|
$-1.79 |
|
$-1.79 |
|